---
title: "180 Life Sciences (ATNF.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ATNF.US.md"
symbol: "ATNF.US"
name: "180 Life Sciences"
industry: "Biotechnology"
datetime: "2026-05-20T01:55:38.933Z"
locales:
  - [en](https://longbridge.com/en/quote/ATNF.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ATNF.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ATNF.US.md)
---

# 180 Life Sciences (ATNF.US)

## Company Overview

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States. The company product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed phase 2a and phase 2b proof-of-concept clinical trials for early-stage Dupuytren’s Contracture; and Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -62.98 | 584 | - | - | - |
| PB | 201.54 | 467 | 201.54 | 201.54 | 3.61 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ATNF.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ATNF.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ATNF.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ATNF.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**